ANNOUNCEMENT

Reserve your seat now for MedCity CONVERGE. Use code ’MEDCITY’ and save 50% off the onsite price.

FindTheBest raises $11M to build comparison shopping for everything

March 5, 2013 4:59 pm by | 0 Comments

I was sold on the idea of FindTheBest the second I saw that it lets users compare sperm banks.

This isn’t because I’m at all interested in sperm banks (honest!), but rather because the existence of the sperm banks comparisons proved to me that the FindTheBest model worked, and could be applied to just about everything.

Investors are impressed as well and have helped FindTheBest raise $11 million in a second round of funding. Led by new investor New World Ventures, the round was joined by Montgomery & Co, Kleiner Perkins, Caufield & Byers, and FindTheBest CEO (and DoubleClick founder) Kevin O’Connor. 

FindTheBest offers visitors unbiased, data-driven comparisons across hundreds of topics, products, and device categories. Think of something like the electronics-focused Decide, and then extrapolate that to just about everything else, including colleges, health insurance, and payroll software.

Advertisement

FindTheBest, which raised $6 million in 2011, says it plans to use the funding both to dip its feet in new markets and to continue to monetize its platform.

Headquartered in Summerland, Calif. FindTheBest was founded in 2009. VentureBeat has previously used the company’s platform to compare tablets, which I thought was pretty cool.

Photo:Shutterstock


Filed under: Business

This article originally appeared on VentureBeat

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.

Know What's Next in Medical Innovation

Get the latest stories, carefully selected by our editorial team, in your inbox each morning.



By Ricardo Bilton,

Visit website | More posts by Author

0 comments

Stay Up To Date

Next Story
Cancer drug firm Oncotide develops compounds that may restore cells’ tumor-suppressing abilities
Close